Incidence of Mutation and Deletion in Topoisomerase IIα mRNA of Etoposide and mAMSA-resistant Cell Lines
- 1 October 2001
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (10), 1133-1137
- https://doi.org/10.1111/j.1349-7006.2001.tb01069.x
Abstract
The efficacy of all chemotherapeutic agents is limited by the occurrence of drug resistance. To further understand resistance to topoisomerase II inhibitors, 50 sublines were isolated as single clones from parental cells by exposure to VP–16 (etoposide) or mAMSA (m–amsacrine). Subsequently, a population of cells from each subline was exposed to three–fold higher drug concentrations allowing 16 stable sublines to be established at higher extracellular drug concentration. Finally, 66 sublines were picked up. The frequency and nature of mutations in the topoisomerase II gene in the drug–selected cell lines were evaluated. In order to screen a large number of cell lines, an RNAse protection assay was developed and mismatches were observed in 13.6% of resistant cell lines (12% of resistant cell lines exposed to lower drug concentrations and 18.8% of resistant cell lines exposed to higher drug concentrations). Some of these mutations are located in vital regions of topoisomerase II (phosphorylation sites in the C–terminal or N–terminal, and nuclear localizing signal of topoisomerase II). Our findings suggest that mutations of topoisomerase II gene are an important and frequent mechanism of resistance to topoisomerase II inhibitors.Keywords
This publication has 17 references indexed in Scilit:
- Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal TruncationJapanese Journal of Cancer Research, 2001
- Expression of Drug Resistance Genes in VP-16 and mAMSA-selected Human Carcinoma CellsJapanese Journal of Cancer Research, 2001
- [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines].1997
- Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.1997
- [Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines].1997
- Threonine 1342 in Human Topoisomerase IIα Is Phosphorylated Throughout the Cell CyclePublished by Elsevier BV ,1996
- Structure and mechanism of DNA topoisomerase IINature, 1996
- Cell Cycle Phase-specific Phosphorylation of Human Topoisomerase IIαJournal of Biological Chemistry, 1995
- DNA topoisomerase-targeting antitumor agents and drug resistanceAnti-Cancer Drugs, 1992
- Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoterNucleic Acids Research, 1984